No, you don't understand economics. Think about how stupid what you said is. You're talking about revenue. Why would you expect a company to make a lot in revenues when their entire ability to earn revenue is based on FDA approval which they haven't gotten yet? Think harder dude. Also, market cap, balance sheets, means nothing for this company. You think the people running this company are selling this product which will dominant a multi billion dollar industry for 5 freakin dollars? Dream on. You aren't even close. You clearly don't have any experience with how pharm companies work. If you did, you would know that major pharm companies have bought products not 1/3 as good as this companies for 15 to 30 dollars a share. They buy on what they think they can make off the product. Not what the company is making on it. This company is a small company. They don't have the ability to market the product all over the world. Major pharm companies do. It's what they think they will make on the product and the company who owns the product thinks that company will make which will determine the price.
I've explained this to you many times and you still can't grasp it. This will be the last time I explain it to you. My advice is when the stock starts running up after approval, you sell. Back up your words and dump it since you don't think it will go very high. The rest of us who know better will hold. For the record Rodman, I like you as a poster. I respect that you are long on this stock. However, you're looking at balance sheets and finance things. Penny stocks don't work like that. Whether they hit huge depends on supply, demand, potential and the greed of big companies.
When these greedy pigs in these major pharm companies look at buying a company like this. They don't sit there and look at the balance sheet of the company or the market cap. They could care less. They are sitting there thinking about the billions they could make off of this product and what happens if some other schmuck pharm company outbids them for it who is a competitor. Greed. That is what will determine the price and there is a lot of greed in the pharm industry. Offering billions for pharm companies is a drop in a bucket.
I bought stock on 3 things. One, the guy running it is really smart. Two the product is great and is far better than any other garbage out. Three, the pathetic greed of pharm companies to make billions more on top of the billions they are already making.
News 
Market Data 
Discover 
